Orphanet: Search for an orphan drug
x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Marketing authorization with orphan designation - USA

  • Tradename: XOSPATA
  • ATC code : L01XE54
  • EU Number: -
  • MA date : 28/11/2018
  • MA holder: ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

Therapeutic indication

Treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.